These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15610304)

  • 21. Growth and division of peroxisomes.
    Schrader M; Fahimi HD
    Int Rev Cytol; 2006; 255():237-90. PubMed ID: 17178468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapy for nonalcoholic fatty liver disease.
    Moseley RH
    J Clin Gastroenterol; 2008 Apr; 42(4):332-5. PubMed ID: 18277910
    [No Abstract]   [Full Text] [Related]  

  • 23. Dietary sesamin and docosahexaenoic and eicosapentaenoic acids synergistically increase the gene expression of enzymes involved in hepatic peroxisomal fatty acid oxidation in rats.
    Arachchige PG; Takahashi Y; Ide T
    Metabolism; 2006 Mar; 55(3):381-90. PubMed ID: 16483883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipolytic PPAR activation: new insights into the intersection of triglycerides and inflammation?
    Ziouzenkova O; Plutzky J
    Curr Opin Clin Nutr Metab Care; 2004 Jul; 7(4):369-75. PubMed ID: 15192437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisomal fatty acid beta-oxidation is not essential for virulence of Candida albicans.
    Piekarska K; Mol E; van den Berg M; Hardy G; van den Burg J; van Roermund C; MacCallum D; Odds F; Distel B
    Eukaryot Cell; 2006 Nov; 5(11):1847-56. PubMed ID: 16963628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel functions of acyl-CoA thioesterases and acyltransferases as auxiliary enzymes in peroxisomal lipid metabolism.
    Hunt MC; Alexson SE
    Prog Lipid Res; 2008 Nov; 47(6):405-21. PubMed ID: 18538142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic lipid metabolism and non-alcoholic fatty liver disease.
    Tessari P; Coracina A; Cosma A; Tiengo A
    Nutr Metab Cardiovasc Dis; 2009 May; 19(4):291-302. PubMed ID: 19359149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD36-dependent fatty acid uptake regulates expression of peroxisome proliferator activated receptors.
    Drover VA; Abumrad NA
    Biochem Soc Trans; 2005 Feb; 33(Pt 1):311-5. PubMed ID: 15667335
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptors and the metabolic syndrome.
    Bragt MC; Popeijus HE
    Physiol Behav; 2008 May; 94(2):187-97. PubMed ID: 18191967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple expression control mechanisms of peroxisome proliferator-activated receptors and their target genes.
    Tan NS; Michalik L; Desvergne B; Wahli W
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):99-105. PubMed ID: 15860251
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisomes, lipid metabolism and lipotoxicity.
    Wanders RJ; Ferdinandusse S; Brites P; Kemp S
    Biochim Biophys Acta; 2010 Mar; 1801(3):272-80. PubMed ID: 20064629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
    Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
    J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peroxisomal-mitochondrial oxidation in a rodent model of obesity-associated insulin resistance.
    Noland RC; Woodlief TL; Whitfield BR; Manning SM; Evans JR; Dudek RW; Lust RM; Cortright RN
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E986-E1001. PubMed ID: 17638705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Some novel insights into the pathogenesis of alcoholic steatosis.
    Lakshman MR
    Alcohol; 2004 Aug; 34(1):45-8. PubMed ID: 15670665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The nudix hydrolase 7 is an Acyl-CoA diphosphatase involved in regulating peroxisomal coenzyme A homeostasis.
    Reilly SJ; Tillander V; Ofman R; Alexson SE; Hunt MC
    J Biochem; 2008 Nov; 144(5):655-63. PubMed ID: 18799520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD).
    Ahmed MH; Byrne CD
    Drug Discov Today; 2007 Sep; 12(17-18):740-7. PubMed ID: 17826687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Nuclear Receptor PPARs and magnesium].
    Fujii H
    Clin Calcium; 2005 Nov; 15(11):52-64. PubMed ID: 16272614
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative proteomic comparison of mouse peroxisomes from liver and kidney.
    Mi J; Kirchner E; Cristobal S
    Proteomics; 2007 Jun; 7(11):1916-28. PubMed ID: 17474143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atherosclerosis; cell biology and lipoproteins: lipid metabolism, eicosanoids, peroxisome proliferator activated receptors and the atherogenic process.
    Davidson J; Rotondo D
    Curr Opin Lipidol; 2006 Aug; 17(4):489-91. PubMed ID: 16832175
    [No Abstract]   [Full Text] [Related]  

  • 40. Lipid metabolism and liver inflammation. I. Hepatic fatty acid uptake: possible role in steatosis.
    Bradbury MW
    Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G194-8. PubMed ID: 16407588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.